Discounted Cash Flow (DCF) Analysis Unlevered

The Gabelli Healthcare & Wellness T... (GRX)

$9.5

-0.12 (-1.25%)
All numbers are in Millions, Currency in USD
Stock DCF: - | 9.5 | undervalue

Operating Data

Year
A/P
2020
Actual
2021
Projected
2022
Projected
2023
Projected
2024
Projected
2025
Projected
Revenue 25.01-----
Revenue (%)
EBITDA 24.24-----
EBITDA (%)
EBIT ------
EBIT (%)
Depreciation ------
Depreciation (%)

Balance Sheet Data

Year
A/P
2020
Actual
2021
Projected
2022
Projected
2023
Projected
2024
Projected
2025
Projected
Total Cash 0.01-----
Total Cash (%)
Account Receivables 5.11-----
Account Receivables (%)
Inventories ------
Inventories (%)
Accounts Payable 3.65-----
Accounts Payable (%)
Capital Expenditure ------
Capital Expenditure (%)

Weighted Average Cost Of Capital

Share price $ 9.5
Beta 1.065
Diluted Shares Outstanding 17.04
Cost of Debt
Tax Rate 0.00
After-tax Cost of Debt 5.00%
Risk-Free Rate
Market Risk Premium
Cost of Equity 8.831
Total Debt -
Total Equity 161.90
Total Capital 161.90
Debt Weighting 0.00
Equity Weighting 100.00
Wacc

Build Up Free Cash

Year
A/P
2020
Actual
2021
Projected
2022
Projected
2023
Projected
2024
Projected
2025
Projected
Revenue 25.01-----
EBITDA 24.24-----
EBIT ------
Tax Rate 0.00%0.00%0.00%0.00%0.00%0.00%
EBIAT ------
Depreciation ------
Accounts Receivable ------
Inventories ------
Accounts Payable ------
Capital Expenditure ------
UFCF ------
WACC
PV UFCF -----
SUM PV UFCF -

Terminal Value

Growth in perpetuity method:
Long-term growth rate
WACC (%) 8.83
Free cash flow (t + 1) -
Terminal Value -
Present Value of Terminal Value -

Intrinsic Value

Enterprise Value -
Net Debt -0.01
Equity Value -
Shares Outstanding 17.04
Equity Value Per Share -